ArticleJTO clinical and research reports2026

Caution Against Uncritical Adoption of Neoadjuvant Chemoimmunotherapy Followed by Definitive Radiotherapy in Stages II to III NSCLC: In Response to Adib et al.

Steven J Feigenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.